[Present status and the future of diabetic nephropathy].
Haneda
Masakazu
M
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003928:Diabetic Nephropathies / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D010348:Patient Care Team; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction; D012084:Renin-Angiotensin System / Q000502:physiology; D000092502:Renin Inhibitors
D000806:Angiotensin-Converting Enzyme Inhibitors; D000451:Mineralocorticoid Receptor Antagonists; D000092502:Renin Inhibitors